|
English
|
正體中文
|
简体中文
|
2832009
|
|
???header.visitor??? :
33545058
???header.onlineuser??? :
977
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"nguyen p a"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2021 |
The Effectiveness and Safety of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Stage III/IV: A Multicenter Study
|
Hsu, J.C.;Nguyen, P.-A.;Chen, Y.-T.;Yang, S.-C.;Lin, C.-C.;Yang, Yang Y.-H.;Lin, Y.-C.;Hsia, T.-C.;Hsieh, Hsieh H.-C.;Wu, J.-S.;Chang, Chang C.-P.;Feng, Y.-H.;Lin, P.-C.;Hsu, P.-C.;Tzeng, H.-E.;Chien, S.-C.;Chang, W.-C.;Chang, Chang C.-C.;Yang, H.-C.;Lee, C.M.;Lu, C.Y. |
| 臺大學術典藏 |
2020-08-12T02:50:38Z |
Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas
|
Li Y.-C.; CHAO-CHI HO; Wu C.-W.; Lee T.-F.;Tseng Y.-C.;Nguyen P.A.;Li Y.-C.;Chao-Chi Ho;Wu C.-W.; Lee T.-F.; Tseng Y.-C.; Nguyen P.A. |
| 臺大學術典藏 |
2020-07-21T06:46:17Z |
Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas
|
Tseng Y.-C.; Nguyen P.A.; Li Y.-C.; CHAO-CHI HO; Wu C.-W.; Lee T.-F. |
| 臺北醫學大學 |
2014 |
Co-occurrence of second primary malignancy in patients with thyroid cancer
|
HSU, C.-H.;HUANG, C.-L.;HSU, Y.-H.;IQBAL, U;NGUYEN, P.-A.;Jian, W.-S. |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
